Cargando…

Author Correction: Mutated processes predict immune checkpoint inhibitor therapy benefit in metastatic melanoma

Detalles Bibliográficos
Autores principales:	Patterson, Andrew, Auslander, Noam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Author Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10514182/ https://www.ncbi.nlm.nih.gov/pubmed/37735162 http://dx.doi.org/10.1038/s41467-023-41662-3

Ejemplares similares

Mutated processes predict immune checkpoint inhibitor therapy benefit in metastatic melanoma
por: Patterson, Andrew, et al.
Publicado: (2022)

Author Correction: Interleukin 17 signaling supports clinical benefit of dual CTLA-4 and PD-1 checkpoint inhibition in melanoma
por: Váraljai, Renáta, et al.
Publicado: (2023)

Author Correction: Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma
por: Lauss, Martin, et al.
Publicado: (2020)

Author Correction: Hyperprogression under Immune Checkpoint Inhibitor: a potential role for germinal immunogenetics
por: Refae, Sadal, et al.
Publicado: (2020)

Author Correction: Estimation of the timing of BAP1 mutation in uveal melanoma progression
por: Uner, Ogul E., et al.
Publicado: (2021)

Author Correction: Neutrophil to lymphocyte ratio influences impact of steroids on efficacy of immune checkpoint inhibitors in lung cancer brain metastases
por: Lauko, Adam, et al.
Publicado: (2021)

Author Correction: Neutrophil to lymphocyte ratio influences impact of steroids on efficacy of immune checkpoint inhibitors in lung cancer brain metastases
por: Lauko, Adam, et al.
Publicado: (2022)

Author Correction: The effects of mutational processes and selection on driver mutations across cancer types
por: Temko, Daniel, et al.
Publicado: (2020)

Author Correction: Divergent mutational processes distinguish hypoxic and normoxic tumours
por: Bhandari, Vinayak, et al.
Publicado: (2022)

Author Correction: Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma
por: Liu, David, et al.
Publicado: (2020)

Author Correction: A phase 1/2 trial of an immune-modulatory vaccine against IDO/PD-L1 in combination with nivolumab in metastatic melanoma
por: Kjeldsen, Julie Westerlin, et al.
Publicado: (2022)

Correction: Efficacy of immune checkpoint inhibitors for in-transit melanoma
Publicado: (2020)

Author Correction: Neoadjuvant relatlimab and nivolumab in resectable melanoma
por: Amaria, Rodabe N., et al.
Publicado: (2023)

Author Correction: RGS7 is recurrently mutated in melanoma and promotes migration and invasion of human cancer cells
por: Qutob, Nouar, et al.
Publicado: (2019)

Author Correction: The impact of rare germline variants on human somatic mutation processes
por: Vali-Pour, Mischan, et al.
Publicado: (2023)

Author Correction: Immune-checkpoint protein VISTA critically regulates the IL-23/IL-17 inflammatory axis
por: Li, Na, et al.
Publicado: (2018)

Author Correction: Fundamental immune–oncogenicity trade-offs define driver mutation fitness
por: Hoyos, David, et al.
Publicado: (2022)

Author Correction: Telomere length and survival in primary cutaneous melanoma patients
por: Rachakonda, Sivaramakrishna, et al.
Publicado: (2018)

Author Correction: The incidence and clinical analysis of non‑melanoma skin cancer
por: Ciążyńska, Magdalena, et al.
Publicado: (2021)

Combining checkpoint inhibitors and BRAF-targeted agents against metastatic melanoma
por: Cooper, Zachary A., et al.
Publicado: (2013)

Author Correction: A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns
por: Jiao, Wei, et al.
Publicado: (2022)

Author Correction: Combination of anti-vascular agent - DMXAA and HIF-1α inhibitor - digoxin inhibits the growth of melanoma tumors
por: Smolarczyk, Ryszard, et al.
Publicado: (2020)

Author Correction: The repertoire of mutational signatures in human cancer
por: Alexandrov, Ludmil B., et al.
Publicado: (2023)

Author Correction: Selective HDAC6 inhibitors improve anti-PD-1 immune checkpoint blockade therapy by decreasing the anti-inflammatory phenotype of macrophages and down-regulation of immunosuppressive proteins in tumor cells
por: Knox, Tessa, et al.
Publicado: (2019)

Author Correction: Impact of hormone receptor status and distant recurrence-free interval on survival benefits from trastuzumab in HER2-positive metastatic breast cancer
por: Yang, Hai-Yuan, et al.
Publicado: (2018)

Author Correction: Supply chains create global benefits from improved vaccine accessibility
por: Wang, Daoping, et al.
Publicado: (2023)

Author Correction: Nifuroxazide exerts potent anti-tumor and anti-metastasis activity in melanoma
por: Zhu, Yongxia, et al.
Publicado: (2022)

Author Correction: Dynamic causal modelling of immune heterogeneity
por: Parr, Thomas, et al.
Publicado: (2021)

Author Correction: Pectin as an Extraordinary Natural Kinetic Hydrate Inhibitor
por: Xu, Shurui, et al.
Publicado: (2020)

Author Correction: Prime editor-mediated correction of a pathogenic mutation in purebred dogs
por: Kim, Dong Ern, et al.
Publicado: (2022)

Author Correction: Dopamine-dependent prefrontal reactivations explain long-term benefit of fear extinction
por: Gerlicher, A. M. V., et al.
Publicado: (2019)

Author Correction: Therapeutic benefit of Muse cells in a mouse model of amyotrophic lateral sclerosis
por: Yamashita, Toru, et al.
Publicado: (2021)

Author Correction: The RhoA dependent anti-metastatic function of RKIP in breast cancer
por: Kalpana, Gardiyawasam, et al.
Publicado: (2023)

Author Correction: Tumour gene expression signature in primary melanoma predicts long-term outcomes
por: Garg, Manik, et al.
Publicado: (2022)

Author Correction: Mutations in COMP cause familial carpal tunnel syndrome
por: Li, Chunyu, et al.
Publicado: (2020)

Author Correction: Establishment and equilibrium levels of deleterious mutations in large populations
por: Viljoen, Johan W., et al.
Publicado: (2020)

Author Correction: Loss-of-function uORF mutations in human malignancies
por: Schulz, Julia, et al.
Publicado: (2021)

Author Correction: Retrospective analysis of somatic mutations and clonal hematopoiesis in astronauts
por: Brojakowska, Agnieszka, et al.
Publicado: (2022)

Author Correction: The rate and molecular spectrum of mutation are selectively maintained in yeast
por: Liu, Haoxuan, et al.
Publicado: (2023)

Author Correction: Mutation bias reflects natural selection in Arabidopsis thaliana
por: Monroe, J. Grey, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0nm5opqasq48f86f2ujcfocm0g